نتایج جستجو برای: clobetasol propionate

تعداد نتایج: 5821  

2013
ASHNI VERMA SUKHDEV SINGH RUPINDER KAUR AJAY KUMAR UPENDRA K JAIN

Objective: The present study was aimed to develop topical gel of Clobetasol propionate with the help of carbopol-934 and Hydroxypropyl methylcellulose K4m as gelling agents. Polymers play major role in various characterization parameters of topical gel such as in vitro release and rheological properties. Methods: Gels were prepared with carbopol-934 and Hydroxypropyl methylcellulose K4m as gell...

Journal: :International Journal of Advances in Medicine 2022

The most widely prescribed drugs for the treatment of a variety dermatoses are Topical corticosteroids (TC). These medications approved inflammatory and pruritic manifestations dermatologic disorders due to their powerful symptom-relieving impact. Clobetasol propionate (CP) is popular (TC) used relieve itching, redness, oedema caused by skin disorders. Anti-inflammatory, anti-pruritic, vasocons...

2013
Luís Antônio Dantas Silva Stephânia Fleury Taveira Eliana Martins Lima Ricardo Neves Marreto

Clobetasol propionate (CP) is a potent topical corticosteroid that causes several cutaneous and systemic side effects. In the present work, CP was encapsulated in nanostructured lipid carriers (NLCs) to increase drug retention in the outer skin layers and improve the safety of topical therapy. NLCs were prepared using a microemulsion technique with a mixture of lecithin, taurodeoxycholate, stea...

2016
D. Maor C. Heyes A. Howard E. Veysey

Background: Vulval lichen planus (VLP) is a debilitating, often treatment resistant condition, for which there is limited evidence-based guidance on assessment and management. Aim: To describe current management of women with VLP in the multi-disciplinary vulval dermatology clinic at the Royal Women’s Hospital (RWH), Melbourne, to compare this with reported practices in the literature and provi...

2017
Georgi Tchernev Matteo Zanardelli Cristiana Voicu Ilko Bakardzhiev Torello Lotti Jacopo Lotti Katlein França Atanas Batashki Uwe Wollina

A 16 years old female patient, affected by atopic dermatitis and rhinoconjunctivitis allergica since childhood, requested a dermatologic consultation for lesions which had appeared after 3 months of local treatment with clobethasole propionate. The histological analysis confirmed the diagnosis of dyshidrotic eczema and the microbiological smears demonstrated a significant infection with Staphyl...

Journal: :British medical journal 1975
C F Allenby R A Main R A Marsden C G Sparkes

Thirty-nine patients (15 outpatients and 24 inpatients) with a variety of skin diseases affecting variable areas of the body surface were treated with clobetasol propionate ointment (Dermovate). Before and after treatment the adrenal response to an intramuscular injection of tetracosactrin was rested and additional 9 am plasma cortisol levels were measured at intervals during treatment. A satis...

2009
Taner ŞENYİĞİT Cristina PADULA Özgen ÖZER Patrizia SANTI

INTRODUCTION Topical glucocorticoids (TG) are the most frequently prescribed drugs by dermatologists. Their clinical effectiveness in the treatment of psoriasis and atopic dermatitis is related to their vasoconstrictive, anti-inflammatory, immunosuppressive and anti-proliferative effects. Despite their benefit in the therapy of inflammatory diseases, TG are associated number of side effects tha...

Abedini Robabe Chams-Davatchi Cheyda Daneshpazhooh Maryam Esmaili Nafiseh Ghiasi Maryam Mortazavi Hossein Roghani Iman

Background: Pemphigus vulgaris (PV) is an autoimmune bullous disorder that is fatal if left untreated. High dose systemic corticosteroids are the basis of therapy. The addition of immunosuppressive agents has improved the disease outcome and reduced the required corticosteroid dose and related toxicity. Mycophenolate mofetil is increasingly used as a steroid-sparing agent in immunotherapy of PV...

Journal: :Acta dermato-venereologica 2007
Dimitrios Rigopoulos Stamatis Gregoriou Andreas Katsambas

Sir, Nail psoriasis affects 20–55% of psoriatic patients. It often represents a significant cause of distress because of the visible lesions and the chronic course of the disease. Treatment options include corticosteroids, vitamin D3 analogues, 5-fluorouracil, urea, anthralin, cyclosporine and radiotherapy (1). Tazarotene is an acetylenic retinoid with documented therapeutic results in skin pso...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید